CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Option exercise Director acquired 400 shares (option exercise)
- 4 Option exercise President and CEO acquired 961 shares (option exercise)
- 4 Option exercise SVP, CFO acquired 638 shares (option exercise)
- 4 Option exercise SVP, GC, BD & Corp Affairs acquired 638 shares (option exercise)
- 4 Shares withheld for taxes SVP, CMO gave up 156 shares (to pay taxes)
- 4 Option exercise Director acquired 400 shares (option exercise)
- 4 Shares withheld for taxes Executive Chair gave up 406 shares (to pay taxes)
- 4 Option exercise Director acquired 400 shares (option exercise)
- 4 Option exercise Director acquired 400 shares (option exercise)
- 4 Option exercise Director acquired 400 shares (option exercise)
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Regulation FD disclosure
Page 2 of 38 · 742 filings